For instance, growing the prostate cancer LNCaP cells in castrated mice and treating them with the AR inhibitor enzalutamide shows that elevated glucocorticoid receptor (GR) expression is involved in the resistance process [62]. This evidence concerns the gene NR3C1 and prostate carcinoma.